Formaldehyde → 4-[5-Methyl-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzoic acid

HRID 1498821

Reaktionsgleichung

Reaktionsgleichung von HRID 1498821
C(O[C:6]([N:8]1[CH2:13][CH2:12][N:11]([C:14]2[S:15][C:16]([CH3:28])=[C:17]([C:19]3[CH:24]=[CH:23][C:22]([C:25]([OH:27])=[O:26])=[CH:21][CH:20]=3)[N:18]=2)[CH2:10][CH2:9]1)=O)(C)(C)C.CC(O)=O.C(O[Na])(C)=O.C=O.[BH3-]C#N.[Na+]>Cl.O1CCOCC1>[CH3:28][C:16]1[S:15][C:14]([N:11]2[CH2:10][CH2:9][N:8]([CH3:6])[CH2:13][CH2:12]2)=[N:18][C:17]=1[C:19]1[CH:24]=[CH:23][C:22]([C:25]([OH:27])=[O:26])=[CH:21][CH:20]=1

Komponenten

7

Versuchsvorschrift

4-[4-(4-Carboxy-phenyl)-5-methyl-thiazol-2-yl]piperazine-1-carboxylic acid tert-butyl ester (0.421 mmol) was dissolved in 4M HCl in 1,4-dioxane, and stirred at room temperature for 1 h. The solvent was then removed under vacuum, and the residue 4-(5-methyl-2-piperazin-1-yl-thiazol-4-yl)-benzoic acid was suspended in methanol (10 ml) and treated with AcOH/AcONa buffer (pH ˜5.5, 5 ml), and formaldehyde (0.547 mmol). The reaction mixture was stirred at room temperature for 1 h, then treated with NaCNBH3 (0.547 mmol) and stirred at room temperature overnight. The solvent was then removed under vacuum, and the residue was purified by column chromatography to afford the title compound (0.403 mmol, 95%).

Aufarbeitung

  1. customThe solvent was then removed under vacuum
  2. stirringThe reaction mixture was stirred at room temperature for 1 h
  3. stirringstirred at room temperature overnight
  4. customThe solvent was then removed under vacuum
  5. customthe residue was purified by column chromatography

Quellen und Nachweise

ORD-Eintrag
ord-ce47cdc278f84b04ab91f653222d6e92
Quelldatensatz
uspto-grants-2015_12
Patentnummer
US09200006B2

Verknüpfte Notizen

Wird geladen…